ARCHIVES

Idaho Senator Pressure DeVita On Taking Neutron Facility

This article is from The Cancer Letter archive.

Vol. 14 No. 19 | May 6, 1988

Download PDF Visit The Full Archive

Related Articles

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013